Context and Objective: Nonalcoholic fatty liver disease (NAFLD) and its more severe form
with steatohepatitis (NASH) are common in patients with type 2 diabetes mellitus (T2DM). …

Plasma aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase
[ALT]) are usually increased in patients with nonalcoholic fatty liver disease (NAFLD). …

Context: Patients with nonalcoholic fatty liver disease (NAFLD) are at increased risk of
cardiovascular disease, and atherogenic lipoproteins may play an important role. Objective: The …

Background & Aims The role of plasma vitamin D deficiency in the development of non-alcoholic
fatty liver disease (NAFLD) and steatohepatitis (NASH) remains poorly understood. …

The underlying mechanisms responsible for the development and progression of non-alcoholic
fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) are unclear. …

The Endocrine Society’s initial online posting of “High Prevalence of Nonalcoholic Fatty Liver
Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase …

Hepatitis is defined as inflammation of the liver. This inflammation can be acute and self-limited,
chronic (leading to cirrhosis and an increased risk for hepatocellular carcinoma), or …

Diarrhea causes monovalent and divalent ion losses that can influence clinical outcome.
Unlike the losses of monovalent ions, such as Na + , K + , Cl − , and HCO 3 − , which are …

Purpose: A 34-year-old male with no past medical history presented to the emergency
department with abdominal pain, nausea, and vomiting, all of which had been worsening over the …

Background/aims: Non-invasive methods for liver fibrosis diagnosis predict clinical outcomes
in viral hepatitis and fatty liver. No study has specifically targeted NASH. Methods: We …